InsidersTradesSigma
Track the 오리엔트바이오 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 오리엔트바이오 has published 10 public disclosures. The latest transaction was reported on 8 July 2026 (Purchase). Among the most active insiders: 오리엔트. The full history is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
10 of 10 declarations
Orient Bio 是一家专注于健康和制药领域的公司，在 XKRX 上市。该公司致力于生物制药产品的开发和分销。